Evidence map›Paper›PMID 31936539›Full record

ArticleMarine drugs2020

Fucoidan Derived from

Hyocheol Bae, Jin-Young Lee, Changwon Yang, Gwonhwa Song, Whasun Lim

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Enzymatic Hydrolysates fromMarine drugs · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Hyocheol BaeDepartment of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
Jin-Young LeeDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Changwon YangDepartment of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
Gwonhwa SongDepartment of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
Whasun LimDepartment of Food and Nutrition, College of Science and Technology, Kookmin University, Seoul 02707, Korea.
Korea University · KRKookmin University · KRMedical College of Wisconsin · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marine organisms are sources of several natural compounds with potential clinical use. However, only a few marine-based pharmaceuticals have been approved for use due to limited knowledge on their biological activities. Here, we identified the functional role of fucoidan extracted from

Indexed as

AnimalsAntineoplastic AgentsCalciumCell Line, TumorCell ProliferationEndoplasmic ReticulumFemaleFucusHomeostasisHumansNeovascularization, PathologicOvarian NeoplasmsPolysaccharidesStress, PhysiologicalToxicity TestsZebrafishAntineoplastic AgentsCalciumfucoidanPolysaccharidesangiogenesiscalcium homeostasisfucoidanmarine drugovarian cancer

Identifiers

PMID31936539
PMCPMC7024155
OpenAlexW2999330425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.